SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-005724
Filing Date
2014-11-14
Accepted
2014-11-14 11:18:18
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnib_10q.htm 10-Q 936780
2 CERTIFICATION ex_311.htm EX-31.1 17027
3 CERTIFICATION ex_312.htm EX-31.2 17272
4 CERTIFICATION ex_32.htm EX-32 11959
  Complete submission text file 0001354488-14-005724.txt   3013102

Data Files

Seq Description Document Type Size
5 tnib-20140930.xml EX-101.INS 308009
6 tnib-20140930.xsd EX-101.SCH 34653
7 tnib-20140930_cal.xml EX-101.CAL 34361
8 tnib-20140930_def.xml EX-101.DEF 35264
9 tnib-20140930_lab.xml EX-101.LAB 181921
10 tnib-20140930_pre.xml EX-101.PRE 116094
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 141221570
SIC: 2834 Pharmaceutical Preparations